Yulun Wang, the head of research and development at Teladoc Health and a pioneer in the field of remote and robotic surgery, has joined the volunteer Board of Directors for Cottage Health. Wang has deep roots in the area, having earned his doctorate in electrical and computer engineering from UC Santa Barbara. He then spent Read More →
AeroVironment, an aerial drone company based in Simi Valley, reached an agreement Dec. 8 to acquire Telerob, a German robotics company, in a deal worth approximately $45.4 million in cash. AeroVironment also released its second quarter 2021 earnings on Dec. 8, revealing an increase in revenue, but a 71% drop in earnings from the previous Read More →
Thousand Oaks mayor Al Adam gave the annual State of the City address on Dec. 8, centered around three things he said are most important to the city’s growth: jobs, the environment and housing. In his virtual address, Adam said the influx of biotech companies in recent years has been a big win for the Read More →
Presidio Residential Capital, Coastal Community Builders and Williams Homes are teaming up again to build almost 300 more homes in San Luis Obispo County.
In a show of rising frustration over Gov. Gavin Newsom’s Southern California-wide “stay-at-home” order, the counties of Ventura, Santa Barbara and San Luis Obispo are jointly petitioning the state to loosen the rules for some 1.5 million residents. In a draft statement reviewed by the Business Times, the three counties said they will shortly be Read More →
Santa Barbara District Attorney Joyce Dudley announced Dec. 7 that her office has reached a settlement with Southern California Edison over a grading project that caused environmental harm in the Mission Canyon area. Civil and criminal complaints alleged that between Dec. 4 and Dec. 16, 2019, SCE did unpermitted road work along 1.6 miles of Read More →
MannKind Corp., a biotech company based in Westlake Village, announced Dec. 7 that it has acquired a QrumPharma, a privately held biotech company, in a $12.5 million deal. MannKind has purchased all outstanding capital stock of QrumPharma for $3.5 million in cash and just over 3 million shares of MannKind common stock. At MannKind’s stock Read More →